Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 53

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 53
---
 specific markets;                                                                                                     |
| ● | we may conduct a reverse stock split of our common stock to meet the requirements of Nasdaq, which may adversely impact the market price and liquidity of our common stock; |
| ● | the volatility of, and decline in, our stock price; and                                                                                                                     |
| ● | our ability to obtain the necessary financing to fund our operations and effect our strategic development plan.                                                             |

<div align='center'>5</div>

All forward-looking statements and risk factors included in this prospectus
are made as of the date hereof, and all forward-looking statements and risk factors included in documents incorporated herein by reference
are made as of their original date, in each case based on information available to us as of the date hereof, or in the case of documents
incorporated by reference, the original date of any such document, and we assume no obligations to update any forward-looking statement
or risk factor, unless we are required to do so by law. If we do update one or more forward-looking statements, no inference should be
drawn that we will make updates with respect to other forward-looking statements or that we will make any further updates to those forward-looking
statements at any future time.

Forward-looking statements may include our plans and objectives for
future operations, including plans and objectives relating to our products and our future economic performance, projections, business
strategy and timing and likelihood of success. Assumptions relating to the foregoing involve judgments with respect to, among other things,
future economic, competitive and market conditions, future business decisions, demand for our products and services, and the time and
money required to successfully complete development and commercialization of our technologies, all of which are difficult or impossible
to predict accurately and many of which are beyond our control.

Any of the assumptions underlying the forward-looking statements contained
in this prospectus could prove inaccurate and, therefore, we cannot assure you that any of the results or events contemplated in any of
such forward-looking statements will be realized. Based on the significant uncertainties inherent in these forward-looking statements,
the inclusion of any such statement should not be regarded as a representation or as a guarantee by us that our objectives or plans will
be achieved, and we caution you against relying on any of the forward looking-statements contained herein.

Our trademarks currently used in the United States include Applied
DNA Sciences®, SigNature® molecular tags, SigNature® T molecular tags, fiberTyping®, SigNify®, Beacon®, CertainT®,
Linear